TABLE 5.

Weighted odds ratios (95% confidence intervals) for impaired fasting glucose of participants across quartiles of serum uric acid (Men = 2,498, women = 2,650).

	Case/Participants	Crudea	Model 1a	Model 2a
Men†
Q1	635/2,498	1.00 (Ref.)	1.00 (Ref.)	1.00 (Ref.)
Q2	685/2,498	0.8 (0.6–1.29)	0.8 (0.5–1.3)	0.8 (0.5–1.4)
Q3	567/2,498	1.7 (1.1–2.56) *	1.7 (1.1–2.6) *	1.2 (0.7–2.1)
Q4	611/2,498	2.1 (1.4–3.03) **	2.1 (1.4–3.1) **	1.4 (0.8–2.2)
Women†
Q1	663/2,650	1.00 (Ref.)	1.00 (Ref.)	1.00 (Ref.)
Q2	694/2,650	1.5 (0.8–2.9)	1.5 (0.8–2.9)	1.3 (0.6–3.1)
Q3	648/2,650	1.8 (1.0–3.3)	1.8 (1.0–3.2)	1.5 (0.7–3.1)
Q4	645/2,650	4.9 (2.8–8.7) **	4.8 (2.7–8.5) **	2.7 (1.4–5.5) **

^aCalculated using binary logistic regression.

^†Men: Q1 (uric acid ≤ 309.30 μmol/L), Q2 (309.30 < uric acid ≤ 356.90 μmol/L), Q3 (356.90 < uric acid ≤ 404.50 μmol/L), and Q4 (uric acid > 404.50 μmol/L). Women: Q1 (uric acid ≤ 232.00 μmol/L), Q2 (232.00 < uric acid ≤ 273.60 μmol/L), Q3 (273.60 < uric acid ≤ 321.20 μmol/L), and Q4 (uric acid > 321.20 μmol/L).

Model 1 adjusted for race.

Model 2 adjusted for race, body mass index, waist circumference, drinking status, education level, hypertension, serum triglyceride, total cholesterol, and urate-lowering therapy.

*P < 0.05.

**P < 0.01.